Ameriprise’s Replimune Group REPL Stock Holding History

Ameriprise’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$96.4K	Buy	12,595 +10	+0.1%	+$76	﹤0.01%	3961
2025 Q4	$122K	Buy	12,585 +196	+2%	+$1.67K	﹤0.01%	3984
2025 Q3	$51.9K	Sell	12,389 -141,823	-92%	-$906K	﹤0.01%	4018
2025 Q2	$1.43M	Buy	+154,212	New	+$1.35M	﹤0.01%	3112
2024 Q3	–	Sell	-18,555	Closed	-$167K	–	3997
2024 Q2	$167K	Buy	+18,555	New	+$129K	﹤0.01%	3716
2023 Q4	–	Sell	-186,779	Closed	-$3.2M	–	3968
2023 Q3	$3.2M	Sell	186,779 -848	-0.5%	-$16.7K	﹤0.01%	2595
2023 Q2	$4.36M	Sell	187,627 -19,852	-10%	-$388K	﹤0.01%	2448
2023 Q1	$3.66M	Sell	207,479 -7,200	-3%	-$171K	﹤0.01%	2525
2022 Q4	$5.84M	Sell	214,679 -1,990	-0.9%	-$41.4K	﹤0.01%	2179
2022 Q3	$3.74M	Buy	+216,669	New	+$4.13M	﹤0.01%	2435

Other funds holding REPL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ameriprise's REPL Position: Q1 2026 in Review

Ameriprise increased its Replimune Group (REPL) stake by 0.08% in Q1 2026, buying an estimated $76 and bringing the position to 12,595 shares worth $96.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3961.

Ameriprise first reported a position in REPL in Q3 2022 and has held it in 10 quarters since. The position peaked at $5.84M in Q4 2022. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

Ameriprise held 12,595 shares of Replimune Group worth $96.4K as of Q1 2026.
Ameriprise bought 10 Replimune Group shares in Q1 2026, an estimated $76.
Replimune Group made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3961 holding.
Ameriprise first reported a position in Replimune Group in Q3 2022 and has held it in 10 quarters since.
Ameriprise's Replimune Group position peaked at $5.84M in Q4 2022.
180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.